| Typicality: | 0.366 |
| Saliency: | 0.271 |
| for between three and six months | 6 | temporal |
| against four groups of neisseria meningitides | 5 | transitive-object |
| against seasonal and pandemic influenza a | 4 | other |
| vaccine → confer → protection | 22 |
| negative | neutral | positive |
| 0.142 | 0.550 | 0.308 |
| Raw frequency | 22 |
| Normalized frequency | 0.271 |
| Modifier score | 0.500 |
| Perplexity | 177.799 |